News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Myriad Genetics, Inc. Profit Up; at Ease with ’10 Street View
August 26, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Myriad Genetics's fourth-quarter income from continuing operations rose 71 percent and said it was comfortable with the current market estimates for fiscal 2010, sending shares up 7 percent after the bell.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoffs
Tempest Cuts 80% of Staff While Considering Strategic Alternatives
April 21, 2025
·
1 min read
·
Angela Gabriel
Manufacturing
After Phase III Win, Lilly Promises to Manufacture Weight-Loss Pill in US
April 21, 2025
·
2 min read
·
Tristan Manalac
Business
Elevation Mulls Strategic Alternatives, Including Closure, Amid Activist Pressure
April 18, 2025
·
2 min read
·
Tristan Manalac
Deals
Unusual New Fund Launches to Unlock Some $30B of Capital ‘Trapped’ in Public Biotechs
April 18, 2025
·
3 min read
·
Annalee Armstrong